Adaptin Bio
Pre-clinicalOur key discovery Brain Bispecific T cell Engager (BRiTE) hitchhiking drug delivery platform A unique combination of novel T cell engager + specifically manipulated polyclonal T cells Learn More Benefit at
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $55M
About
Our key discovery Brain Bispecific T cell Engager (BRiTE) hitchhiking drug delivery platform A unique combination of novel T cell engager + specifically manipulated polyclonal T cells Learn More Benefit at
Drug Delivery
Funding History
3Total raised:$55M
Series A$35MMay 15, 2023
Seed$12MMar 15, 2023
Seed$8MFeb 15, 2022